Editor’s Note: this post has been updated with new information regarding the Allergan recall of BioCell textured breast implants and tissue expanders.
Since 2016, there has been more progress made regarding a rare type of cancer that researchers found to have a possible association with certain kinds of breast implants. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a cancer of the immune system. Over the years since the condition was first reported, there have been 573 unique cases reported cases around the world. Research has shown that BIA-ALCL appears to be mostly associated with textured silicone implants, though it could occur in a much smaller percentage of smooth implants filled with silicone and—much more rare but possible—with saline as well. On July 24th, 2019, the Allergan corporation issued a worldwide recall of BioCell textured breast implants and tissue expanders. The recall includes products in the Natrelle® brand of implants and tissue expanders.
When caught in early stages, it is significantly more likely that BIA-ALCL can be cured. This makes it very important that women who have breast implants be sure to maintain the recommended number of check-ups and mammograms, in addition to regular self-exams, to identify any potential irregularities as quickly as possible. It is important to note that the FDA is not suggesting or recommending an implant removal procedure for patients who have BioCell textured implants/tissue expanders and are not showing symptoms. The document listed via the link at the bottom of this page can provide you with more information.
Please click on the link below for answers to some frequently asked questions about BIA-ALCL and Allergan’s BioCell textured breast implant and tissue expander recall. This information can give you more details about the rarity of the condition, as well as the risks, symptoms, and factors that have been associated with BIA-ALCL. If you have additional questions or concerns, we encourage you to contact our practice today.
